Co-Diagnostics, Inc. (CODX) Stock Analysis
A live, multi-source view of Co-Diagnostics, Inc. (CODX): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Sector: Healthcare · Industry: Medical Devices · United States · 115 employees · co-dx.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Co-Diagnostics, Inc. (CODX) had a market capitalization of $8.1M (forward -1.4) and a beta of 2.85; the shares traded in a 52-week range of $0.94 – $46.50 (-87.5% over the year).
- Market cap
- $8.1M
- Enterprise value
- $5.4M
- Forward P/E
- -1.4
- Price / book
- 0.45
- EPS (trailing)
- $-25.89
- EPS (forward)
- $-0.83
- Payout ratio
- 0.0%
- 52-week range
- $0.94 – $46.50
- 52-week change
- -87.5%
- Beta
- 2.85
- Average volume
- 458,368
- Shares outstanding
- 7.0M
- Short % of float
- 5.91%
- Profit margin
- 0.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-08
In RapidTradeView’s 2026-09-08 scan of the US universe, Co-Diagnostics, Inc. (CODX) last closed at $1.16 (the last completed close before that scan).
Technicals at the scan: RSI 31 (neutral territory), price -9.4% versus its 20-day average, 20-day versus 50-day average spread -31.6%, MACD histogram 0.04.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish.
Next scheduled company event: in 69 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for CODX in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
CODX has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Co-Diagnostics, Inc. (CODX) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell CODX.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.